Eric Poma
Directeur Général chez MOLECULAR TEMPLATES, INC.
Fortune : 29 611 $ au 30/04/2024
Postes actifs de Eric Poma
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| MOLECULAR TEMPLATES, INC. | Directeur/Membre du Conseil | 01/01/2000 | - |
| Directeur Général | 01/01/2000 | - | |
| Directeur Technique/Scientifique/R&D | 01/01/2000 | - | |
| Fondateur | 01/01/2000 | - | |
Molecular Templates OpCo, Inc.
 Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Molecular Templates OpCo, Inc. provides medical services. The company is headquartered in Austin, TX. | Directeur/Membre du Conseil | - | - |
| Directeur Général | - | - |
Historique de carrière de Eric Poma
Anciens postes connus de Eric Poma
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 01/01/2001 | - |
Innovive Pharmaceuticals, Inc.
 Innovive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is developing compounds for the treatment of cancer. It currently have four products in development; INNO-406, tamibarotene, INNO-206 and INNO-406. The Group operates in the United States of America. | Corporate Officer/Principal | 01/03/2005 | - |
| Secrétaire Général | 01/03/2005 | 25/10/2013 |
Formation de Eric Poma
| The Leonard N Stern School of Business | Masters Business Admin |
| University of North Carolina at Chapel Hill | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MOLECULAR TEMPLATES, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Innovive Pharmaceuticals, Inc.
Innovive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is developing compounds for the treatment of cancer. It currently have four products in development; INNO-406, tamibarotene, INNO-206 and INNO-406. The Group operates in the United States of America. | Health Technology |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
Molecular Templates OpCo, Inc.
Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Molecular Templates OpCo, Inc. provides medical services. The company is headquartered in Austin, TX. | Finance |
